![Thomas Turalski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Turalski
Directeur/Membre du Conseil chez
RYVU THERAPEUTICS S.A.
Fortune : 91 571 $ au 31/05/2026
Profil
Thomas Turalski is currently a Member of the Supervisory Board at Ryvu Therapeutics SA. Previously, he worked as a Senior Analyst at Perceptive Advisors LLC and as a Principal at Exis Capital Management, Inc. In addition, he was a Member at Acerta Pharma BV.
Mr. Turalski also held the position of Senior Analyst at Perceptive Advisors LLC from 2003 to 2005.
He obtained his undergraduate degree from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RYVU THERAPEUTICS SA 0,09% | 30/09/2025 | 20 100 ( 0,09% ) | 91 571 $ | 31/05/2026 |
Postes actifs de Thomas Turalski
| Sociétés | Poste | Début |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Turalski
| Sociétés | Poste | Fin |
|---|---|---|
Exis Capital Management, Inc.
 Exis Capital Management, Inc. Investment ManagersFinance Exis Capital Management uses quantitative strategies to manage a multi-strategy hedge fund. The firm focuses on a variety of sectors, including but not limited to, industrial services, health technology, electronic technology, producer manufacturing and non-energy minerals, as well as high yield and distressed debt. Exis Capital Management invests long/short primarily in the stocks of US mid-cap and large-cap stocks. The firm maintains a very high turnover rate. | Corporate Officer/Principal | 31/12/2007 |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Analyst-Equity | 01/01/2005 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Corporate Officer/Principal | - |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Analyst-Equity | - |
Formation de Thomas Turalski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Exis Capital Management, Inc.
Exis Capital Management, Inc. Investment ManagersFinance Exis Capital Management uses quantitative strategies to manage a multi-strategy hedge fund. The firm focuses on a variety of sectors, including but not limited to, industrial services, health technology, electronic technology, producer manufacturing and non-energy minerals, as well as high yield and distressed debt. Exis Capital Management invests long/short primarily in the stocks of US mid-cap and large-cap stocks. The firm maintains a very high turnover rate. | Finance |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
